Skip to main content

26-03-2024 | Alzheimer's Disease | News

CONy 2024

Clinical evidence to guide decisions on extended lecanemab treatment lacking

Author: Lucy Piper

medwireNews: Clinical evidence to date is not sufficient to be able to demonstrate a benefit from extending treatment with lecanemab beyond 18 months, so without really knowing should we be discontinuing treatment in those who currently receive it?

Related topics